Media Centre

Press releases

Real lives

Highlights from the region

Crisis in the Sahel

Mali Emergency

Photo essays

Facts and Figures

 

Liberia begins protecting its children against pneumococcal disease

MONROVIA, Liberia, 9 January 2014 – Children across Liberia are now receiving protection against one of the leading vaccine-preventable killers of children as the country today celebrates the introduction of pneumococcal vaccine (PCV).

Liberian President Ellen Johnson Sirleaf was joined at the launch event, held at the JFK Medical Center in Monrovia, by representatives of the GAVI Alliance who provides the vaccines, cabinet ministers and senior politicians, representatives of the diplomatic corps, UNICEF, WHO, health workers, parents and babies.

Speaking at the event, President Sirleaf said, “Health is a priority for Liberia, and we are grateful for the support from partners to introduce this new vaccine. But the responsibility for delivering services to the population is with the country. Liberia is committed to allocate more resources to health including immunization”.

“Liberia has a most impressive story to share on the progress that can be made in immunization, and consequently child survival, in spite of the challenges facing the country as a result of their civil war,” said Helen Evans, Deputy CEO of the GAVI Alliance speaking at the launch event. “The introduction of this vaccine will further reduce the death and disability caused by pneumonia, specifically amongst children under the age of five who are most vulnerable.”

UNICEF Country Representative, Sheldon Yett said that the introduction of PCV is the best gift the Liberian government can give to its children. “Far too many children are dying from diseases that a simple injection could have prevented. UNICEF and WHO will continue to work with the government and other partners to improve immunization services and the introduction of additional vaccines,” he said.

Pneumococcal disease is a leading cause of pneumonia, which accounts for almost one fifth of deaths of children under five worldwide. In Liberia alone it is estimated that 7,000 children die each year from pneumococcal disease (14% of the children in the age group).

Vaccinating all children, with particular emphasis on those hardest to reach, is one of the best public health investments a country can make. It provides an enormous return on investment, regardless of how it is measured, whether in terms of deaths averted, fewer illnesses or lower health costs, Yett added.

In 2014, the pneumonia vaccine will reach about 90% of children under one year old in Liberia (about 140,000 children), according to the Ministry of Health and Social Welfare. The pneumococcal vaccine will be a part of the national routine immunization programme.

Since 2010, GAVI Alliance funding has helped 38 developing countries roll out the pneumococcal vaccine. Liberia is the first to do so this year. More than 50 GAVI-eligible countries have been approved for Alliance support to introduce pneumococcal conjugate vaccine into their national immunization programmes.

UNICEF and WHO supports the Ministry of Health and Social Welfare in capacity building of health workers and procurement, installation and maintenance of cold chain equipment, programme monitoring and impact evaluation. The network of cold chain system in the country ensures equitable delivery of vaccine services to all children, including those hardest to reach.

About GAVI
The GAVI Alliance is a public-private global health partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisation in poor countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, civil society organisations, the Bill & Melinda Gates Foundation and other private sector partners. GAVI uses innovative finance mechanisms, including co-financing by recipient countries, to secure sustainable funding and adequate supply of quality vaccines. Since 2000, GAVI has contributed to the immunisation of an additional 440 million children and the prevention of approximately 6 million future deaths. Learn more at www.gavialliance.org and connect with us on Facebook and Twitter.

GAVI is funded by governments [Australia, Canada, Denmark, France, Germany, Ireland, Italy, Japan, Luxembourg, the Netherlands, Norway, the Republic of Korea, the Russian Federation, Spain, South Africa, Sweden, the United Kingdom, United States of America], the European Commission, the Bill & Melinda Gates Foundation, as well as private and corporate partners [Absolute Return for Kids, Anglo American plc., The Children’s Investment Fund Foundation, Comic Relief, Dutch Postcode Lottery, His Highness Sheikh Bin Zayed Al Nahyan, JP Morgan, “la Caixa” Foundation, LDS Charities, Lions Clubs, OPEC and Vodafone].

About UNICEF
UNICEF promotes the rights and wellbeing of every child, in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere.

For more information, please contact:
Rob Kelly, Senior Manager, Communications,
Tel: +41 79 745 20 31
email: rkelly@gavialliance.org

Kinley Dorji, Reports Officer, UNICEF Liberia
Tel: +231-770-267-111;
email: kdorji@unicef.org
www.unicef.org/liberia.htm
www.facebook.com/liberia.unicef; twitter@unicef_liberia

 

 

 
Search:

 Email this article

unite for children